CTRI/2020/04/024543
Not yet recruiting
Phase 4
An open label, phase IV, randomized clinical trial of ArnikaPlus Combo Pack on hair problems
Allen Laboratories Limited0 sites0 target enrollmentTBD
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Allen Laboratories Limited
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Male and female participants in the age group of 18\-40 years.
- •2\.Participants willing to give informed consent.
- •3\.Participants willing to comply with the study procedures.
- •4\.Participants who are fit and no need any hospital administration.
- •5\.Complaints for diffuse hair loss/ slow growth of hair.
- •6\.Complaints for dandruff and lice.
- •7\.Complaints for bad quality of hair (elasticity, strength, fragility, longevity, smoothness).
- •8\.Complaints for fungal infection.
Exclusion Criteria
- •1\.History of systemic or cutaneous malignancy or lesions.
- •2\.History of psoriasis, polycystic ovarian syndrome.
- •3\.Advanced or poorly controlled thyroidisms, diabetes and anemia.
- •4\.Unstable cardiovascular disease.
- •5\.Clinically significant medical or psychiatric disease.
- •6\.Evidence of immunocompromised state.
- •7\.Serious local infection (e.g. cellulites, abscess) or systemic infection (e.g. pneumonia, septicemia) within six months prior to enrollment.
- •8\.Pregnant and lactating women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Clinical trial to evaluate the effects of Fydrane® and standard protocol on ocular surface after cataract surgery.CataractsMedDRA version: 20.0 Level: PT Classification code 10007739 Term: Cataract System Organ Class: 10015919 - Eye disordersMedDRA version: 20.0 Level: PT Classification code 10063797 Term: Cataract operation System Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]EUCTR2017-003277-34-ESaboratoires Théa50
Completed
Phase 4
RituxiMab in INDuction therapy for living donor renal transplantatioive donor renal transplantationSurgeryISRCTN95769119Guy's and St Thomas' Hospital NHS Foundation Trust (UK)316
Recruiting
Phase 4
A open label, phase IV clinical trial examining the efficacy of Prothrombinex alone verses Prothrombinex combined with fresh frozen plasma in patients who require Warfarin reversal.The efficacy to reverse the effect of warfarin by prothrombinex aloneBlood - Clotting disordersACTRN12607000567426Frankston Hospital40
Active, not recruiting
Phase 1
DETOX StudyHIVMedDRA version: 20.0Level: LLTClassification code 10001509Term: AIDSSystem Organ Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]EUCTR2018-001158-82-ESFundación SEIMC-GESIDA110
Active, not recruiting
Phase 1
An open-label, randomized, Phase IV study, to assess the efficacy and safety of tildrakizumab in patients with moderate to severe chronic plaque psoriasis who are non-responders to dimethyl fumarate therapyEUCTR2019-000817-35-GBAlmirall250